Onwubiko Chinwendu, Shires Courtney, Quin Lisa R, Swiatlo Edwin, McDaniel Larry S
Department of Microbiology, The University of Mississippi Medical Center, Jackson, MS 39216, USA.
FEMS Immunol Med Microbiol. 2007 Jun;50(1):119-25. doi: 10.1111/j.1574-695X.2007.00245.x. Epub 2007 Apr 23.
Streptococcus pneumoniae is the main causative agent of acute otitis media in children. Serotype-based vaccines have provided some protection against otitis media, but not as much as anticipated, demonstrating the need for alternative vaccine options. Pneumococcal otitis media isolates were obtained from children 5 years old or younger from hospitals around Mississippi in the prevaccine era (1999-2000). These isolates were compared by capsular typing, pneumococcal surface protein A (PspA) family typing, antibiotic susceptibility, and DNA fingerprinting. Our study shows that there is great genetic variability among pneumococcal clinical isolates of otitis media, except with regard to PspA. Therefore, efforts focused on the development of a PspA-based pneumococcal vaccine would be well placed.
肺炎链球菌是儿童急性中耳炎的主要病原体。基于血清型的疫苗已为预防中耳炎提供了一定的保护作用,但效果未达预期,这表明需要其他疫苗选择。在疫苗接种前时代(1999 - 2000年),从密西西比州各地医院5岁及以下儿童中获取肺炎球菌性中耳炎分离株。通过荚膜分型、肺炎球菌表面蛋白A(PspA)家族分型、抗生素敏感性和DNA指纹图谱对这些分离株进行比较。我们的研究表明,除PspA外,肺炎球菌性中耳炎临床分离株之间存在很大的基因变异性。因此,专注于开发基于PspA的肺炎球菌疫苗的努力是恰当的。